Sorrento Therapeutics
Stock Forecast, Prediction & Price Target
Sorrento Therapeutics Financial Estimates
Sorrento Therapeutics Revenue Estimates
Sorrento Therapeutics EBITDA Estimates
Sorrento Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $39.98M N/A | $52.90M 32.30% | $62.83M 18.77% | Avg: $382.71M Low: $382.71M High: $382.71M avg. 509.04% | Avg: $591.40M Low: $591.40M High: $591.40M avg. 54.52% | Avg: $761.58M Low: $761.58M High: $761.58M avg. 28.77% | |
Net Income
% change YoY
| $-308.56M N/A | $-429.01M -39.03% | $-559.33M -30.37% | Avg: $33.54M Low: $33.54M High: $33.54M avg. 105.99% | Avg: $184.49M Low: $184.49M High: $184.49M avg. 450% | Avg: $280.94M Low: $280.94M High: $280.94M avg. 52.27% | |
EBITDA
% change YoY
| $-275.69M N/A | $-383.45M -39.08% | $-364.52M 4.93% | Avg: $-382.71M Low: $-382.71M High: $-382.71M avg. -4.99% | Avg: $-591.40M Low: $-591.40M High: $-591.40M avg. -54.52% | Avg: $-761.58M Low: $-761.58M High: $-761.58M avg. -28.77% | |
EPS
% change YoY
| -$1.34 N/A | -$1.46 -8.95% | -$1.33 8.90% | Avg: $0.08 Low: $0.08 High: $0.08 avg. 106.01% | Avg: $0.44 Low: $0.44 High: $0.44 avg. 450% | Avg: $0.67 Low: $0.67 High: $0.67 avg. 52.27% | |
Operating Expenses
% change YoY
| $231.57M N/A | $407.91M 76.15% | $407.88M -0.00% | Avg: $1.20B Low: $1.20B High: $1.20B avg. 194.47% | Avg: $1.85B Low: $1.85B High: $1.85B avg. 54.52% | Avg: $2.39B Low: $2.39B High: $2.39B avg. 28.77% | |
FAQ
What is Sorrento Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 202.75% in 2025-2027.
We have gathered data from N/A analysts. Their low estimate is 33.54M, average is 33.54M and high is 33.54M.
What is Sorrento Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 197.44% in 2025-2027.
We have gathered data from N/A analysts. Their low revenue estimate is $382.71M, average is $382.71M and high is $382.71M.
What is Sorrento Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 202.76% in 2025-2027.
We have gathered data from N/A analysts. Their low earnings per share estimate is $0.08, average is $0.08 and high is $0.08.